Objective Systemic lupus erythematosus (SLE) is a multisystem autoimmune disease characterised by variable treatment responses. We investigated the transcriptional landscape associated with treatment ...

Patients with cutaneous lupus erythematosus who used hydroxychloroquine had a significantly reduced risk of developing systemic lupus erythematosus.

Received Clearance from the U.S. Food and Drug Administration (FDA) for Clinical Trials of Budoprutug in Primary Membranous Nephropathy (pMN), ...

In a new study, researchers explored experiences, perceptions, and health effects of a newly developed healthy lifestyle ...

Therefore, clarifying how negative immune checkpoints function and the mechanisms involved can provide a new idea for the clinical treatment of diseases. This Research Topic will focus on the ...

Sana revolutionizes treatments for diabetes, cancer, and autoimmune diseases. SANA has high cash burn and dilution risks. See ...

New research suggests the use of oral prednisone should be limited in patients with systemic lupus erythematosus with a history of recurrent pericarditis.

Baseline factors linked to SLE flares during pregnancy included thrombocytopenia and a history of LN, while antimalarial therapy demonstrated protective effects.

系统性红斑狼疮（SLE）是一种典型的“自作自受”的免疫系统错误，它让免疫系统误以为健康细胞是敌人，开始大举进攻。这种慢性疾病，常常给患者带来全身性的疼痛和不适，尤其是在皮肤、关节、肾脏等部位表现最为明显。

CRISPR Therapeutics poised for growth with international potential and clinical assets. Read why I rate CRSP stock a Strong ...

Members of the Systemic Lupus Erythematosus International Collaborating Clinics (SLICC) group along with experienced ...

SLE is a multisystem autoimmune disease where periods of disease activity, often difficult to predict, can cause irreversible disease damage. This study aimed to develop a patient-centric predictive ...